Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.58M Buy
10,446
+1,101
+12% +$167K 0.01% 694
2025
Q4
$994K Sell
9,345
-1,102
-11% -$124K 0.01% 817
2025
Q3
$1.1M Buy
10,447
+330
+3% +$29.6K 0.01% 787
2025
Q2
$855K Buy
10,117
+2,836
+39% +$191K 0.01% 804
2025
Q1
$427K Buy
7,281
+870
+14% +$70K 0.01% 1119
2024
Q4
$518K Buy
6,411
+1,576
+33% +$124K 0.01% 925
2024
Q3
$386K Buy
4,835
+1,087
+29% +$106K 0.01% 1051
2024
Q2
$469K Buy
3,748
+862
+30% +$82.3K 0.01% 922
2024
Q1
$242K Buy
+2,886
New +$227K 0.01% 1129

Other funds holding CAMT

Vident Advisory's CAMT Position: Q1 2026 in Review

Vident Advisory increased its Camtek (CAMT) stake by 12% in Q1 2026, buying an estimated $167K and bringing the position to 10,446 shares worth $1.58M. The position accounts for 0.01% of the portfolio, ranked #694.

Vident Advisory first reported a position in CAMT in Q1 2024 and has held it in 9 quarters since. 222 funds tracked by Wall St. Rank hold CAMT as of Q1 2026.

  • Vident Advisory held 10,446 shares of Camtek worth $1.58M as of Q1 2026.
  • Vident Advisory bought 1,101 Camtek shares in Q1 2026, an estimated $167K.
  • Camtek made up 0.01% of Vident Advisory's portfolio in Q1 2026, its #694 holding.
  • Vident Advisory first reported a position in Camtek in Q1 2024 and has held it in 9 quarters since.
  • 222 funds tracked by Wall St. Rank held Camtek as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.